SCHEMBL4634504

SCHEMBL4634504

O=C(Cl)CC(P(=O)(OCc1ccccc1)OCc1ccccc1)P(=O)(OCc1ccccc1)OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.51
ALDH1A1 P00352 4/20 0.47
CETP P11597 3/20 0.44
FOLH1 Q04609 1/20 0.43
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
TP53 P04637 1/20 0.40
LMNA P02545 2/20 0.39
NR4A1 P22736 1/20 0.39
NR4A2 P43354 1/20 0.39
NR4A3 Q92570 1/20 0.39
MAPK1 P28482 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A3 Q01959 1/20 0.39
KMT2A Q03164 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KLK1 P06870 1/20 0.39
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5669129 0.87 TSHR (0.55) TSHRALDH1A1CETPFOLH1NPC1
SCHEMBL17359392 0.81 TSHR (0.49) TSHRALDH1A1CETPFOLH1NPC1
SCHEMBL17357042 0.79 TSHR (0.54) TSHRALDH1A1CETPFOLH1MAPK1
SCHEMBL13892565 0.78 TSHR (0.56) TSHRALDH1A1CETPFOLH1NPC1
SCHEMBL13228165 0.78 TSHR (0.45) TSHRCETPFOLH1TDP1MAPT
SCHEMBL14139643 0.78 TSHR (0.45) TSHRCETPFOLH1LMNAKLK1
SCHEMBL13892549 0.77 TSHR (0.55) TSHRALDH1A1CETPFOLH1NPC1
SCHEMBL23748497 0.76 ALDH1A1 (0.50) TSHRALDH1A1CETPFOLH1NPC1
SCHEMBL11214279 0.76 TSHR (0.50) TSHRALDH1A1CETPFOLH1NPC1
SCHEMBL10832425 0.75 TSHR (0.62) TSHRALDH1A1CETPFOLH1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928890-A2 PHOSPHONATED RIFAMYCINS AND USES THEREOF FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS Targanta Therapeutics Inc. (CA) 2008-06-11 EP disclosed
WO-2007096703-A2 PHOSPHONATED RIFAMYCINS AND USES THEREOF FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS TARGANTA THERAPEUTICS INC. (CA) 2007-08-30 WO disclosed